In Estimated Good Prognosis Patients Could Unexpected "hyporesponse" to Controlled Ovarian Stimulation be Related to Genetic Polymorphisms of FSH Receptor?

Reproductive Sciences

Volumn 23, Issue 8, 2016, Pages 1103-1108

  Alviggi, Carlo ^a   Conforti, Alessandro ^a   Caprio, Francesca ^b   Gizzo, Salvatore ^c   Noventa, Marco ^c   Strina, Ida ^a   Pagano, Tiziana ^a   De Rosa, Pasquale ^a   Carbone, Floriana ^a   Colacurci, Nicola ^b   De Placido, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

controlled ovarian stimulation; FSH receptor; genetic mutation; in vitro fertilization; ovarian response; receptor polymorphism; recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN RECEPTOR; RECOMBINANT FOLLITROPIN; FOLLITROPIN; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED OVARIAN STIMULATION; CONTROLLED STUDY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN POLYMORPHISM; RETROSPECTIVE STUDY; STIMULATION; GENETICS; IN VITRO FERTILIZATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GENOTYPE; HUMANS; OVULATION INDUCTION; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY RATE; PROGNOSIS; RECEPTORS, FSH; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 84978229848     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719116630419     Document Type: Article

References (29)

1. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26 (7): 1616-1624.
2. Gizzo S, Andrisani A, Esposito F, et al. Ovarian reserve test: an impartial means to resolve the mismatch between chronological and biological age in the assessment of female reproductive chances. Reprod Sci. 2014; 21 (5): 632-639.
3. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N,. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril. 2004; 82 (6): 1521-1526.
4. De Placido G, Alviggi C, Perino A, et al.; Italian Collaborative Group on Recombinant Human Luteinizing Hormon. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum. Reprod. 2005; 20 (2): 390-396.
5. De Placido G, Mollo A, Alviggi C, et al. Rescue of in vitro fertilisation cycles by human menopausal gonadotrophinin pituitary down-regulated normogonadotrophic young women characterised by a poor initial response to recombinant follicle stimulating hormone. Hum Reprod. 2001; 16 (9): 1875-1879.
6. Devroey P, Fauser BC, Diedrich K, Evian Annual Reproduction (EVAR) Workshop Group 2008. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update. 2009; 15 (4): 391-408.
7. Alviggi C, Clarizia R, Mollo A, Ranieri A, De Placido G,. Who needs LH in ovarian stimulation? Reprod Biomed Online. 2011; 12 (Suppl 1): 599-607.
8. Alviggi C, Pettersson K, Longobardi S, et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol. 2013; 11: 51.
9. Huhtaniemi I, Jiang M, Nilsson C, Pettersson K,. Mutations and polymorphisms in gonadotropin genes. Mol Cell Endocrinol. 1999; 151 (1-2): 89-94.
10. Haavisto AM, Pettersson K, Bergendahl M, Virkamäki A, Huhtaniemi I,. Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab 1995; 80 (4): 1257-1263.
11. Alviggi C, Clarizia R, Pettersson K, et al. A common LH polymorphism (LH-beta variant) is associated with suboptimal response to GnRH- A long protocol in normogonadotrophin women undergoing ovarian stimulation with r-hFSH. Reprod Biomed Online. 2009; 18 (1): 9-14.
12. Alviggi C, Clarizia R, Pettersson K, et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online. 2011; 22 Suppl 1: S67-S72. doi: 10.1016/S1472-6483(11)60011-4.
13. De Placido G, Alviggi C, Mollo A, et al. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary down regulation. Clin Endocrinol. 2004; 60 (5): 637-643.
14. Alviggi C, Mollo A, Clarizia R, De Placido G,. Exploiting LH in ovarian stimulation. Reprod Biomed Online. 2006; 12 (2): 221-233.
15. Gizzo S, Andrisani A, Noventa M, et al. Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing. Mol Med Rep. 2015; 12 (3): 4219-4229.
16. Perez Mayorga M, Gromoll G, Behre HM, Gassner C, Nieschlag E, Simoni M,. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptore genotype. J Clin Endocrinol Metab. 2000; 85 (9): 3365-3369.
17. Mohiyiddeen L, Nardo LG,. Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: future role in IVF. Hum Fertil (Camb). 2010; 13 (2): 72-78.
18. Yao Y, Ma CH, Tang HL, Hu YF,. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab. 2011; 103 (4): 388-393.
19. Simoni M, Gromoll J, Nieschlag E,. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997; 18 (6): 739-773.
20. Greb R, Grieshaber K, Gromoll J, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamic of the mestrual cycle. J Clin Endocrinol Metab. 2005; 90 (8): 4866-4872.
21. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81 (1): 19-25.
22. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67 (5): 817-821.
23. Patrelli TS, Berretta R, Gizzo S, et al. CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate. Fertil Steril. 2011; 95 (1): 393-396.
24. De Castro F, Ruiz R, Monitoro R, et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril. 2003; 80 (3): 571-576.
25. Behre HM, Greb RR, Mempel A, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005; 15 (7): 451-456.
26. Loutradis D, Patsoula E, Minas V, et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet. 2006; 23 (4): 177-184.
27. Genro VK, Matte U, De Conto E, Cunha-Filho JS, Fanchin R,. Frequent polymorphism of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT). J Assist. Reprod. Genet. 2012; 29 (7): 657-663.
28. Jun JK, Yoon JS, Ku SY, et al. Follicle stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet. 2006; 51 (8): 665-670.
29. Gizzo S, Quaranta M, Andrisani A, et al. Serum stem cell factor assay in elderly poor responder patients undergoing IVF: a new biomarker to customize follicle aspiration cycle by cycle. Reprod Sci. 2016; 23 (1): 61-68.